Downregulation of NOX4 expression by RNA interference or treatment with NOX4 inhibitors such as schisandrin B also notably decreased ROS production in FLT3-ITD-mutated AML, and reduced both in vitro and in vivo FLT3-ITD-driven signaling and cell transformation [33]. The gene discussed is NOX4; the disease is acute myeloid leukemia.